Table of Contents Executive Summary 1 Industry Overview of Transdermal Scopolamine 1.1 Definition of Transdermal Scopolamine 1.2 Transdermal Scopolamine Segment by Type 1.2.1 Global Transdermal Scopolamine Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Tablet Type 1.2.3 Syrups Type 1.2.4 Injections Type 1.2.5 Patch Type 1.2.6 Gel Type 1.3 Transdermal Scopolamine Segment by Applications 1.3.1 Global Transdermal Scopolamine Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Ambulance Center 1.3.5 Others 1.4 Global Transdermal Scopolamine Overall Market 1.4.1 Global Transdermal Scopolamine Revenue (2014-2025) 1.4.2 Global Transdermal Scopolamine Production (2014-2025) 1.4.3 North America Transdermal Scopolamine Status and Prospect (2014-2025) 1.4.4 Europe Transdermal Scopolamine Status and Prospect (2014-2025) 1.4.5 China Transdermal Scopolamine Status and Prospect (2014-2025) 1.4.6 Japan Transdermal Scopolamine Status and Prospect (2014-2025) 1.4.7 Southeast Asia Transdermal Scopolamine Status and Prospect (2014-2025) 1.4.8 India Transdermal Scopolamine Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Transdermal Scopolamine 2.3 Manufacturing Process Analysis of Transdermal Scopolamine 2.4 Industry Chain Structure of Transdermal Scopolamine 3 Development and Manufacturing Plants Analysis of Transdermal Scopolamine 3.1 Capacity and Commercial Production Date 3.2 Global Transdermal Scopolamine Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Transdermal Scopolamine 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Transdermal Scopolamine Production and Capacity Analysis 4.2 Transdermal Scopolamine Revenue Analysis 4.3 Transdermal Scopolamine Price Analysis 4.4 Market Concentration Degree 5 Transdermal Scopolamine Regional Market Analysis 5.1 Transdermal Scopolamine Production by Regions 5.1.1 Global Transdermal Scopolamine Production by Regions 5.1.2 Global Transdermal Scopolamine Revenue by Regions 5.2 Transdermal Scopolamine Consumption by Regions 5.3 North America Transdermal Scopolamine Market Analysis 5.3.1 North America Transdermal Scopolamine Production 5.3.2 North America Transdermal Scopolamine Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Transdermal Scopolamine Import and Export 5.4 Europe Transdermal Scopolamine Market Analysis 5.4.1 Europe Transdermal Scopolamine Production 5.4.2 Europe Transdermal Scopolamine Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Transdermal Scopolamine Import and Export 5.5 China Transdermal Scopolamine Market Analysis 5.5.1 China Transdermal Scopolamine Production 5.5.2 China Transdermal Scopolamine Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Transdermal Scopolamine Import and Export 5.6 Japan Transdermal Scopolamine Market Analysis 5.6.1 Japan Transdermal Scopolamine Production 5.6.2 Japan Transdermal Scopolamine Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Transdermal Scopolamine Import and Export 5.7 Southeast Asia Transdermal Scopolamine Market Analysis 5.7.1 Southeast Asia Transdermal Scopolamine Production 5.7.2 Southeast Asia Transdermal Scopolamine Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Transdermal Scopolamine Import and Export 5.8 India Transdermal Scopolamine Market Analysis 5.8.1 India Transdermal Scopolamine Production 5.8.2 India Transdermal Scopolamine Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Transdermal Scopolamine Import and Export 6 Transdermal Scopolamine Segment Market Analysis (by Type) 6.1 Global Transdermal Scopolamine Production by Type 6.2 Global Transdermal Scopolamine Revenue by Type 6.3 Transdermal Scopolamine Price by Type 7 Transdermal Scopolamine Segment Market Analysis (by Application) 7.1 Global Transdermal Scopolamine Consumption by Application 7.2 Global Transdermal Scopolamine Consumption Market Share by Application (2014-2019) 8 Transdermal Scopolamine Major Manufacturers Analysis 8.1 Baxter International Inc. 8.1.1 Baxter International Inc. Transdermal Scopolamine Production Sites and Area Served 8.1.2 Baxter International Inc. Product Introduction, Application and Specification 8.1.3 Baxter International Inc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 GlaxoSmithKline plc 8.2.1 GlaxoSmithKline plc Transdermal Scopolamine Production Sites and Area Served 8.2.2 GlaxoSmithKline plc Product Introduction, Application and Specification 8.2.3 GlaxoSmithKline plc Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Novartis AG 8.3.1 Novartis AG Transdermal Scopolamine Production Sites and Area Served 8.3.2 Novartis AG Product Introduction, Application and Specification 8.3.3 Novartis AG Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Perrigo Company plc. 8.4.1 Perrigo Company plc. Transdermal Scopolamine Production Sites and Area Served 8.4.2 Perrigo Company plc. Product Introduction, Application and Specification 8.4.3 Perrigo Company plc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Caleb Pharmaceuticals, Inc. 8.5.1 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Sites and Area Served 8.5.2 Caleb Pharmaceuticals, Inc. Product Introduction, Application and Specification 8.5.3 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Myungmoon Pharma Co. LTD. 8.6.1 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Sites and Area Served 8.6.2 Myungmoon Pharma Co. LTD. Product Introduction, Application and Specification 8.6.3 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 9 Development Trend of Analysis of Transdermal Scopolamine Market 9.1 Global Transdermal Scopolamine Market Trend Analysis 9.1.1 Global Transdermal Scopolamine Market Size (Volume and Value) Forecast 2019-2025 9.2 Transdermal Scopolamine Regional Market Trend 9.2.1 North America Transdermal Scopolamine Forecast 2019-2025 9.2.2 Europe Transdermal Scopolamine Forecast 2019-2025 9.2.3 China Transdermal Scopolamine Forecast 2019-2025 9.2.4 Japan Transdermal Scopolamine Forecast 2019-2025 9.2.5 Southeast Asia Transdermal Scopolamine Forecast 2019-2025 9.2.6 India Transdermal Scopolamine Forecast 2019-2025 9.3 Transdermal Scopolamine Market Trend (Product Type) 9.4 Transdermal Scopolamine Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Transdermal Scopolamine Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Transdermal Scopolamine Table Global Transdermal Scopolamine Production (K MT) Growth Rate Comparison by Types (2014-2025) Figure Global Transdermal Scopolamine Production Market Share by Types in 2018 Figure Tablet Type Product Picture Figure Syrups Type Product Picture Figure Injections Type Product Picture Figure Patch Type Product Picture Figure Gel Type Product Picture Table Global Transdermal Scopolamine Consumption (K MT) Comparison by Applications (2014-2025) Figure Global Transdermal Scopolamine Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Ambulance Center Figure Others Figure Global Transdermal Scopolamine Revenue (Million USD) (2014-2025) Figure Global Transdermal Scopolamine Production (K MT) (2014-2025) Figure North America Transdermal Scopolamine Market Size (Million USD) (2014-2025) Figure Europe Transdermal Scopolamine Market Size (Million USD) (2014-2025) Figure China Transdermal Scopolamine Market Size (Million USD) (2014-2025) Figure Japan Transdermal Scopolamine Market Size (Million USD) (2014-2025) Figure Southeast Asia Transdermal Scopolamine Market Size (Million USD) (2014-2025) Figure India Transdermal Scopolamine Market Size (Million USD) (2014-2025) Table Transdermal Scopolamine Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Transdermal Scopolamine in 2018 Figure Manufacturing Process Analysis of Transdermal Scopolamine Figure Industry Chain Structure of Transdermal Scopolamine Table Capacity and Commercial Production Date of Key Manufacturers Table Global Transdermal Scopolamine Manufacturing Plants Distribution Table Transdermal Scopolamine Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Transdermal Scopolamine Capacity (K MT) of Major Manufacturers (2014-2019) Table Transdermal Scopolamine Production (K MT) of Major Manufacturers (2014-2019) Table Transdermal Scopolamine Production Market Share of Major Manufacturers (2014-2019) Figure Transdermal Scopolamine Production Share by Manufacturers in 2018 Table Transdermal Scopolamine Revenue (Million US$) of Major Manufacturers (2014-2019) Table Transdermal Scopolamine Revenue Market Share of Major Manufacturers (2014-2019) Figure Transdermal Scopolamine Revenue Share by Manufacturers in 2018 Table Transdermal Scopolamine Average Price (USD/MT) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Transdermal Scopolamine Production by Regions 2014-2019 (K MT) Table Global Transdermal Scopolamine Production Market Share by Regions 2014-2019 Figure Global Transdermal Scopolamine Production Market Share by Regions in 2018 Table Global Transdermal Scopolamine Revenue by Regions 2014-2019 (Million USD) Table Global Transdermal Scopolamine Revenue Market Share by Regions 2014-2019 Figure Global Transdermal Scopolamine Revenue Market Share by Regions in 2018 Table Global Transdermal Scopolamine Consumption by Regions 2014-2019 (K MT) Table Global Transdermal Scopolamine Consumption Market Share by Regions 2014-2019 Figure North America Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure North America Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table North America Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure Europe Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure Europe Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table Europe Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure China Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure China Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table China Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure Japan Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure Japan Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table Japan Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure Southeast Asia Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure Southeast Asia Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure India Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT) Figure India Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD) Table India Transdermal Scopolamine Production, Consumption Import and Export (K MT) Figure Global Consumption Transdermal Scopolamine Market Share by Application (2014-2019) Figure Global Value (Consumption) Transdermal Scopolamine Market Share by Application (2014-2019) Table Baxter International Inc. Transdermal Scopolamine Production Sites and Area Served Table Baxter International Inc. Transdermal Scopolamine Product Introduction, Application and Specification Table Baxter International Inc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Baxter International Inc. Transdermal Scopolamine Production Growth Rate (2014-2019) Table Baxter International Inc. Transdermal Scopolamine Production Market Share (2014-2019) Figure Baxter International Inc. Transdermal Scopolamine Revenue Market Share (2014-2019) Table Baxter International Inc. Transdermal Scopolamine Main Business and Markets Served Table GlaxoSmithKline plc Transdermal Scopolamine Production Sites and Area Served Table GlaxoSmithKline plc Transdermal Scopolamine Product Introduction, Application and Specification Table GlaxoSmithKline plc Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table GlaxoSmithKline plc Transdermal Scopolamine Production Growth Rate (2014-2019) Table GlaxoSmithKline plc Transdermal Scopolamine Production Market Share (2014-2019) Figure GlaxoSmithKline plc Transdermal Scopolamine Revenue Market Share (2014-2019) Table GlaxoSmithKline plc Transdermal Scopolamine Main Business and Markets Served Table Novartis AG Transdermal Scopolamine Production Sites and Area Served Table Novartis AG Transdermal Scopolamine Product Introduction, Application and Specification Table Novartis AG Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Novartis AG Transdermal Scopolamine Production Growth Rate (2014-2019) Table Novartis AG Transdermal Scopolamine Production Market Share (2014-2019) Figure Novartis AG Transdermal Scopolamine Revenue Market Share (2014-2019) Table Novartis AG Transdermal Scopolamine Main Business and Markets Served Table Perrigo Company plc. Transdermal Scopolamine Production Sites and Area Served Table Perrigo Company plc. Transdermal Scopolamine Product Introduction, Application and Specification Table Perrigo Company plc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Perrigo Company plc. Transdermal Scopolamine Production Growth Rate (2014-2019) Table Perrigo Company plc. Transdermal Scopolamine Production Market Share (2014-2019) Figure Perrigo Company plc. Transdermal Scopolamine Revenue Market Share (2014-2019) Table Perrigo Company plc. Transdermal Scopolamine Main Business and Markets Served Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Sites and Area Served Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Product Introduction, Application and Specification Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Growth Rate (2014-2019) Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Market Share (2014-2019) Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue Market Share (2014-2019) Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Main Business and Markets Served Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Sites and Area Served Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Product Introduction, Application and Specification Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Growth Rate (2014-2019) Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Market Share (2014-2019) Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue Market Share (2014-2019) Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Main Business and Markets Served Figure Global Transdermal Scopolamine Production (K MT) Growth Rate Forecast 2019-2025 Figure Global Transdermal Scopolamine Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Transdermal Scopolamine Sales Price (USD/MT) Forecast 2019-2025 Figure North America Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure North America Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure Europe Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure China Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure Japan Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure Southeast Asia Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT) Figure India Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K MT) of Transdermal Scopolamine by Type (2019-2025) Table Global Consumption (K MT) of Transdermal Scopolamine by Application (2019-2025) Table Transdermal Scopolamine Distributors List Table Transdermal Scopolamine Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Baxter International Inc. GlaxoSmithKline plc Novartis AG Perrigo Company plc. Caleb Pharmaceuticals, Inc. Myungmoon Pharma Co. LTD.